ArticleFrontiers in immunology2022

Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg.

Xiaoan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.